Company: STAA
Filing Date: 2025-12-11
Form Type: DFAN14A
Source: 0001213900-25-120777
Chunk: 27

Company: STAAR SURGICAL CO
Filing Date: 2025-12-11
Form: DFAN14A
Chunk 27
---
 by third parties, nor has it paid for any such statements or information. Any such statements or in formation should not be viewed as indicating the support of such third party for the views expressed herein. The materials in this presentation have not been prepared or endo rse d by the Company and may not be attributed to the Company in any way. No warranty is made as to the accuracy of the data or information obtained or derived from filings made w ith the SEC by the Company or from any third party source. Facts have been obtained from sources considered reliable but are not guaranteed. Broadwood recognizes that there may be confidential or otherwise non - public information with respect to the Company that could a lter its opinions were such information known. This presentation does not purport to contain all of the information that may be relevant to an evaluation of the Company, th e C ompany’s securities, or the matters described herein. The information expressed herein is unaudited, reflects the judgment of Broadwood only through the date of this presentation, an d is subject to change at any time. Broadwood disclaims any obligation to correct, update or revise this presentation or to otherwise provide any additional materials to a ny recipient of this presentation. All registered or unregistered service marks, trademarks, and trade names referred to in this presentation are the property o f t heir respective owners, and Broadwood’s use herein does not imply an affiliation with, or endorsement by, the owners of such service marks, trademarks and trade names.

CONFIDENTIAL © All rights reserved. Two Seas Capital LP John Ferguson / Joseph Mills Saratoga Proxy Consulting LLC (212) 257 - 1311 / (888) 368 - 0379 info@saratogaproxy.com Scott Deveau / Jeremy Jacobs August Strategic Communications (323) 805 - 8919 broadwood@augustco.com www.LetSTAARShine.com For Investors For Media</div>

Exhibit 2

<div align='center'>Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon

Encouraged that at Least One Member of STAAR’s Board Recognizes the Flaws of the Sale Process and that the Go-Shop Process was Performative

Questions Completeness of Disclosures Given Critical Omission of Inbound Interest from Respected Private Equity Firm that Indicated It Would Pay More than Alcon

Notes That STAAR’s Board Did Not Obtain an Updated Fairness Opinion on the Revised Terms, Despite Meaningful Improvement in Peer Valuations